The FDA issued warning: A rare and potentially fatal side effect associated with commonly prescribed epilepsy medications
The FDA has issued a warning concerning a rare and potentially fatal side effect associated with widely prescribed epilepsy medications. The alert follows the identification of over 40 cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome linked to the seizure medications levetiracetam (known by brand names Keppra or Keppra XR) and clobazam…